New drug targets Hard-to-Treat cancers in early trial
Disease control
Recruiting now
This study is testing an experimental drug called ETX-19477 in people with advanced solid tumors (cancers that have spread or can't be removed). The goal is to find a safe dose and see if it can shrink tumors. About 120 adults with cancers like breast, ovarian, prostate, or other…
Phase: PHASE1, PHASE2 • Sponsor: 858 Therapeutics, Inc. • Aim: Disease control
Last updated Jun 17, 2026 00:31 UTC